Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts.
Abstract
Objective: To study outcomes of multiple sclerosis (MS) patients treated with either glatiramer acetate (Copaxone * ) or interferon beta-1a for once-weekly, intramuscular administration (Avonex dagger )....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767